Article: Advanced Therapy Commercial Supply Chain Lessons for Clinical Trial Success
Article: How to Ensure the Safety of a Cell and Gene Therapy Product During Shipping
White Paper: Logistics by Design - a Framework for Advanced Therapy Developers
Executive Summary: Logistics by Design - a Framework for Advanced Therapy Developers to Create Optimal Logistics Platforms
Logistics by Design (LbD) is a framework for logistics decision making. Using a risk based analysis it identifies the areas within the supply chain that need to be addressed to create a logistics platform that can meet the needs of patients at clinical and commercial scale.
Article: Logistics in Cell and Gene Therapy; as Complex as the Myth Suggests?
Article: The Commercialization of Cell and Gene Therapies: Supplying Patients in Need
Article: Four Trends in Advanced Therapy Logistics and Their Impact on Customs Clearance
White Paper: 13 Ways Logistics Specialists are Transforming Cell and Gene Therapy Supply Chains
Video: Logistics Leaders: The Real Cost of Quality
Article: What's Your Logistics Vision
Every CEO will be able to describe their target patient population, their clinical capability and their strategy for developing a manufacturing process, but how many can describe their strategy for connecting all of this to the patient? That is, what is their logistics vision?
Article: GDP - The Critical Link in Maintaining Quality from GMP to the Patient
Article: Cell and Gene Therapy: the Teenage Years
Take a look at the recent development of Cell and Gene Therapy and how this relatively new medical field will see patients benefiting for years to come.
Article: Delivering a Cost Effective, Practical and Robust Cell Therapy Supply Chain
Overcoming logistical challenges through technology
Article: World Courier to support Advanced Therapies Treatment Centres (ATTCs)
Specialist centres will create and deliver systems to progress advanced therapy development through joint ventures set up by industry, academic and NHS partners
Article: An Interview with Sam Herbert
Sam Herbert, President of World Courier, gives insight into how cell and gene therapies can present new and difficult challenges for manufacturers and what can be done to support manufacturers from a supply chain perspective
Article: How Are Cell and Gene Therapies Challenging Pharma Logistics?
You’re investing hundreds of millions of dollars to develop products to enhance patient care and improve global health. But can your logistics partner meet the challenges?
Article: The Logistics Link in Successful Cell and Gene Therapy Trials
The success of a clinical study depends on the CRO’s or sponsor’s ability to bring together people, processes, and technology in a coordinated effort to improve patient outcomes, one case at a time.
Webinar on-demand: Practical Aspects of Shipping Cell and Gene Therapies
In this webinar on-demand World Courier’s Cell and Gene Therapy specialists share their knowledge with you, and discuss how our practical experience of Cell and Gene shipments is evolving logistics.
Article: Beyond Compliance to Excellence
E-book: Tomorrow's Medicine - Curing One Patient at a Time
To help you understand why personalized therapies require a personalized supply chain, we’ve published Tomorrow’s Medicine: Curing One Patient at a Time – an e-book highlighting the logistics challenges of cell and gene therapies.